| Website | asuragen.com |
| Category | BioTech |
| Phone | 1-877-777-1874 |
| Employees |
| TOTAL | $67.5M |
| VENTURE FUNDING TOTAL | $67.5M |
| Series A, 6/06 Telegraph Hill Partners Growth Capital Fund | $49M |
| Series B, 12/07 PTV Sciences Telegraph Hill Partners Growth Capital Fund | $18.5M |
Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen’s current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.
